Gëftstoffer vun Aminosaier benotzt fir synthetize Protein
Promrat Detail
| NO | Produkter vun Produkter | Cas Nee | Schlësselqualitéit Indikator | |||
| Rengheet | Max. Onwäerts- | Total Léisungsmëttel Reschter | Fiichtegkeet | |||
| 1 | Fmoc-β-Ala-Ala-Ala-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 2 | Fmoc-D-ala-d-ala-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 3 | Fmoc-Β-ala-d-ala-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 4 | Fmoc-arg (pbf) -arg (pbf) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 5 | Fmoc-Β-ala-arg (pbf) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 6 | Fmoc-d-arg (pbf) -R-arg (pbf) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 7 | Fmoc-β-Ala-D-Arg (PBF) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 8 | Fmoc-Homorarg (PBF) -Homoarg (PBF) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 9 | Fmoc-β-ala-homoarg (PBF) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 10 | Fmoc-asn (trt) -asn (trt) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 11 | Fmoc-β-Ala-Astn (Ttr) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 12 | FMOC-ASP (OTBU) -ALL (OTBU) -Oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 13 | Fmoc-β-Ala-Asp (Otbu) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 14 | FMOC-CYS (TT) -CYS (TT) -OH | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 15 | Fmoc-β-Ala-Cys (Ttr) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 16 | Fmoc-Cys (Acm) -CYs (Acm) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 17 | Fmoc-Β-ala-cys (Acm) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 18 | Fmoc-gln (trt) -Gln (trt) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 19 | Fmoc-β-Ala-LUN (TT) -Oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 20 | FMOC-Glu (Otbu) -glu (Otbu) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 21 | Fmoc-Β-ala-Glu (Otbu) -oh.h2o | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 22 | Fmoc-β-Ala-Gly-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 23 | Fmoc-seng (trt) -His (trt) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 24 | Fmoc-Β-ala-seng (trt) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 25 | Fmoc-ile-ile-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 26 | Fmoc-β-Ala-Ile-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 27 | Fmoc-lou-lou-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 28 | Fmoc-β-Ala-Lou-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 29 | FMOC-D-Leu-D-Leu-Oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 30 | Fmoc-Β-ala-d-lou-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 31 | Fmoc-lys (Boc) -lys (Boc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 32 | Fmoc-β-Ala-Lys (Boc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 33 | FMOC-LYS (Alloc) -lys (Alloc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 34 | Fmoc-β-Ala-Lys (Alloc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 35 | Fmoc-Met-Met-Oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 36 | Fmoc-β-Ala-Met-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 37 | Fmoc-orn (Boc) -orn (Boc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 38 | Fmoc-β-Ala-Orn (Boc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 39 | Fmoc-phe-phe-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 40 | Fmoc-Β-ala-phe-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 41 | Fmoc-d-phe-d-phe-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 42 | Fmoc-β-ala-d-phe-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 43 | Fmoc-pro-pro-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 44 | Fmoc-Β-ala-pro-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 45 | Fmoc-ser (tbu) -ver (tbu) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 46 | Fmoc-β-ALA-SER (TBU) -OH | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 47 | Fmoc-ser (trt) -ver (trt) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 48 | Fmoc-β-ALA-SER (TTP) -OH | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 49 | Fmoc-thr (tbu) -thr (tbu) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 50 |
| NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 51 | FMOC-TRP (Boc) -trp (Boc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 52 | Fmoc-Β-ala-trop (Boc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 53 | FMOC-D-TRP (Boc) -D-TRP (Boc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 54 | Fmoc-Β-ala-d-tp (boc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 55 | Fmoc-Tyr (tbu) -tyr (tbu) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 56 | Fmoc-β-ala-Tyr (tbu) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 57 | Fmoc-d-tyr (et) -d-tyr (et) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 58 | Fmoc-β-ala-d-tyr (et) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 59 | Fmoc-tyr (mech) -tyr (mech) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 60 | Fmoc-β-ala-Tyr (mech) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 61 | Fmoc-val-val-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 62 | Fmoc-β-Ala-Val-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 63 | FMOC-D-CIT-D-CIT-OH | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 64 | FMOC-β-ALA-D-CIT-OH | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 65 | Fmoc-β-Ala-Dab-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 66 | Fmoc- (3- (2-Naphetyl) -D-ALA) 2-Oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 67 | Fmoc-Β-ala-3- (2-naphetyl) -d-ala-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 68 | Fmoc- (3- (3-Pyridinyl) -D-ALA) 2-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 69 | Fmoc-Β-ala-3- (3-Pyridinyl) -d-Ala-Oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 70 | Fmoc- (4-Chloro-d-phe) 2-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 71 | Fmoc-β-ALA-4-Chloro-D-Pho-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 72 | Fmoc- (D-4Aph (tbucbm)) 2-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 73 | Fmoc-β-Ala-D-4Aph (Tbucbm) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 74 | Fmoc-aph (l-hr) -ap (l-hor) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 75 | Fmoc-β-Ala-Aph (L-Hor) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 76 | FMOC-LYS (IRP, Boc) -lys (Ipr, Boc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 77 | FMOC-β-Ala-Lys (Ipr, Boc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 78 | Fmoc-β-Alea-aeea-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 79 | Fmoc-aib-aib-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 80 | Fmoc-β-Ala-AIB-Oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 81 | Fmoc-arg-oh | 91000-69-0 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 82 | H-arg (pbf) -oh | 200115-86-2 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 83 | Fmoc-D-arg-oh | 130752-32-8 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 84 | Hd-arg (pbf) -oh | 200116-81-0 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 85 | Fmoc-Homorarg-oh.hcl | 208174-14-5 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 86 | H-homoarg (pbf) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 87 | Fmoc-d-Homoarg-oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 88 | HD-Homoarg (PBF) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 89 | Fmoc-asn-oh | 71989-16-7 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 90 | H-asn (trt) -oh | 132388-58-0 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 91 | Fmoc-asp-oh | 119062-05-4 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 92 | H-ASP (OTBU) -Oh | 3057-74-7 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 93 |
| 135248-89-4 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 94 |
| 2799/7/7 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 95 | H-cleys (Acm) -oh.hl | 28798-28-9 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 96 | Fmoc-gln-oh | 71989-20-3 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 97 | H-gln (trt) -oh | 102747-84-2 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 98 | Fmoc-Glu-Oh | 121343-82-6 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 99 | H-glu (otbu) -oh.h2o | 2419-56-9 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 100. | Fmoc-seng-oh | 116611-64-4 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 101 | H-seng (trt) -oh | 35146-32-8 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 1022 | Boc-seng-oh | 17791-52-5 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 103 | Fmoc-lys-oh | 105047-45-8 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 104 | H-Lys (Boc) -oh | 2418-95-3 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 105. | H-Lys (Alloc) -oh | 6298/3/9 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 1066 | Fmoc-orn-oh.hcl | 201046-57-3 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 107 | H-orn (boc) -oh | 13650-49-2 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 108 | Fmoc-ser-oh | 73724-45-5 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 109 | H-SER (TBU) -OH | 18822-58-7 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 110 | H-ser (trt) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 111 | Fmoc-thr-oh.h2o | 73731-37-0 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 11,2 | H-th (tbu) -oh | 4378-13-6 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 113 | Fmoc-tp-oh | 35737-15-6 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 114 | H-TRP (Boc) -oh | 146645-63-8 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 115 | Fmoc-d-tp-oh | 86123-11-7 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 116 | HD-TRP (Boc) -oh | 201290-11-1 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 117 | Fmoc-tyr-oh | 92954-90-0 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 118 | H-tyr (tbu) -oh | 18822-59-8 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 119 | Fmoc-d-tyr-oh | 112883-29-1 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 120 | HD-TYR (ET) -OH | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 121 | H-tyr (mech) -oh.hl | 67423-44-3 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 1222 | Fmoc-D-4Aph (CBM) -oh | 324017-22-3 | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 123 | HD-4AF (TBUKM) -OH | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 124 | FMOC-LYS (IRP) -Oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
| 1255 | H-Lys (IRP, Boc) -oh | NA | ≥98,0% | ≤1.0% | ≤8,0% | ≤2.0% |
Iwwer
Kompensatioun
D'Genaffex bitt super Qualitéitsprodukter, wann all Produktgliewen bannent den erfuerderleche Beweiser vu genuch Beweiser gemaach ginn, wäerte mir eng Perensiounen u Kompanitiv an Kompensages u Kompensiounen ze umzéieren.
Produktioun
D'Fäegkeete vun Hattrickprodukter, déi sech am Chantographats bedauert, hunn déi Kapazitéiten zu chemmarens Produkter héichnowibre] 46 Spillkeit ginn.
Fuerschung an Entwécklung
Alles méizou plangen Pèoire vum R & D Team fir verschidden nei Produkter ze entwéckelen an geschitt, datt Präsizen a mat der Equipe bleift.
